Metoprolol succinate, a beta-blocker used to treat high blood pressure and heart conditions, is generally considered safe for long-term use. However, like all medications, it can have side effects.
What are the common long-term side effects of metoprolol succinate?
The most frequently reported long-term side effects of metoprolol succinate include fatigue, dizziness, and slowed heart rate (bradycardia) [1]. Some individuals may also experience cold extremities, shortness of breath, and gastrointestinal issues like diarrhea or nausea [1].
Can metoprolol succinate cause mood changes or depression with long-term use?
While not as common, some patients taking metoprolol succinate long-term have reported mood changes, including depression and anxiety [1]. If you experience significant changes in mood, it is important to discuss this with your healthcare provider.
Are there any serious long-term risks associated with metoprolol succinate?
Serious long-term risks are rare but can include an increased risk of heart failure in certain individuals or the worsening of existing heart failure symptoms [1]. Abruptly stopping metoprolol succinate after long-term use can also lead to serious cardiovascular events, such as chest pain or heart attack, which is why a gradual tapering of the dose is recommended under medical supervision [1].
How does metoprolol succinate compare to other beta-blockers for long-term treatment?
Metoprolol succinate is a selective beta-1 blocker, meaning it primarily affects the heart. Other beta-blockers may be non-selective or have different properties, potentially leading to a different side effect profile with long-term use. The choice of beta-blocker for long-term management depends on individual patient factors and specific medical conditions [2].
When does the patent for metoprolol succinate expire?
Metoprolol succinate has been available as a generic medication for many years, as its initial patents have long expired [3]. This availability of generics has made it a more affordable long-term treatment option for many patients.
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/beta-blockers/art-20044522
[3] https://www.drugpatentwatch.com/